Genetics of ADHD dimensions: biological and clinical implications for ADHD

Image may contain: logo, circle.

In this seminar presentation Tetyana Zayats, MD, PhD will give an overview of the field of genome-wide association (GWA) testing in psychiatry and secondary analyses built upon GWA data. She will also provide some examples of the biological and clinical implications of GWA studies using the data from her own research on ADHD, attention deficit hyperactivity disorder.

Tetyana Zayats has a clinical background as an MD and has a PhD in statistical genetics. She is a researcher at the Analytic and Translational Genetic Unit at the Massachusetts General Hospital in Boston and Stanley Center for Psychiatric Research at BROAD Institute of MIT and Harvard.

Dr. Tetyana Zayats’ current research focuses on novel approaches to better our understanding of both biological and clinical aspects of psychiatric disorders, focusing on ADHD. These approaches encompass the analyses of (1) parent-of-origin effects (POE), (2) polygenic risk scores (PRS), (3) epigenome and (4) combined genetic, epigenetic and environmental factors across a lifespan.

In addition to the seminar, Dr. Zayats will host a workshop on genomicSEM in practice (registration required).

Published Sep. 17, 2019 2:53 PM - Last modified Sep. 18, 2019 10:43 AM